Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model.

Brownell AL, Canales K, Chen YI, Jenkins BG, Owen C, Livni E, Yu M, Cicchetti F, Sanchez-Pernaute R, Isacson O.

Neuroimage. 2003 Oct;20(2):1064-75.

PMID:
14568476
2.

Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.

Jenkins BG, Sanchez-Pernaute R, Brownell AL, Chen YC, Isacson O.

J Neurosci. 2004 Oct 27;24(43):9553-60.

3.

Pharmacologic MRI (phMRI) as a tool to differentiate Parkinson's disease-related from age-related changes in basal ganglia function.

Andersen AH, Hardy PA, Forman E, Gerhardt GA, Gash DM, Grondin RC, Zhang Z.

Neurobiol Aging. 2015 Feb;36(2):1174-82. doi: 10.1016/j.neurobiolaging.2014.10.014. Epub 2014 Oct 16.

4.

Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.

Bezard E, Dovero S, Prunier C, Ravenscroft P, Chalon S, Guilloteau D, Crossman AR, Bioulac B, Brotchie JM, Gross CE.

J Neurosci. 2001 Sep 1;21(17):6853-61.

5.

Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.

Madras BK, Gracz LM, Fahey MA, Elmaleh D, Meltzer PC, Liang AY, Stopa EG, Babich J, Fischman AJ.

Synapse. 1998 Jun;29(2):116-27.

PMID:
9593102
7.

SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.

Fischman AJ, Babich JW, Elmaleh DR, Barrow SA, Meltzer P, Hanson RN, Madras BK.

J Nucl Med. 1997 Jan;38(1):144-50.

8.

Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.

Andringa G, Drukarch B, Bol JG, de Bruin K, Sorman K, Habraken JB, Booij J.

Neuroimage. 2005 Jul 15;26(4):1150-8.

PMID:
15908232
9.

Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys.

Elsworth JD, Brittan MS, Taylor JR, Sladek JR Jr, al-Tikriti MS, Zea-Ponce Y, Innis RB, Redmond DE Jr, Roth RH.

Cell Transplant. 1996 Mar-Apr;5(2):315-25.

PMID:
8689042
10.

Cocaine congeners as PET imaging probes for dopamine terminals.

Brownell AL, Elmaleh DR, Meltzer PC, Shoup TM, Brownell GL, Fischman AJ, Madras BK.

J Nucl Med. 1996 Jul;37(7):1186-92.

11.

Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease.

Goldberg JA, Boraud T, Maraton S, Haber SN, Vaadia E, Bergman H.

J Neurosci. 2002 Jun 1;22(11):4639-53.

12.

Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.

Oiwa Y, Eberling JL, Nagy D, Pivirotto P, Emborg ME, Bankiewicz KS.

Front Biosci. 2003 Sep 1;8:a155-66.

PMID:
12957824
13.
14.

Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.

Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T.

Synapse. 1999 Jun 1;32(3):153-64.

PMID:
10340626
15.
16.

Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT.

Morris ED, Babich JW, Alpert NM, Bonab AA, Livni E, Weise S, Hsu H, Christian BT, Madras BK, Fischman AJ.

Synapse. 1996 Nov;24(3):262-72.

PMID:
8923667
18.

Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice.

Yarkov AV, Hanger D, Reploge M, Joyce JN.

Pharmacol Biochem Behav. 2003 Dec;76(3-4):551-62.

PMID:
14643855
20.

Dopamine transporter loss and clinical changes in MPTP-lesioned primates.

Eberling JL, Bankiewicz KS, Pivirotto P, Bringas J, Chen K, Nowotnik DP, Steiner JP, Budinger TF, Jagust WJ.

Brain Res. 1999 Jun 19;832(1-2):184-7.

PMID:
10375668

Supplemental Content

Support Center